Abstract |
A 59-year-old male was found to have advanced gastric cancer with multiple lymph node metastasis including para-aortic lymph nodes(cT3, cN3, cM0, cH0, cP0, cStage IV). Since curative surgery was deemed not feasible, we tried neoadjuvant chemotherapy expecting downstaging of the tumor. S-1(120 mg/body)was orally administered for three weeks followed by one week rest, and CDDP(60 mg/m2)was administered on day 8. Three courses of treatment resulted in a marked shrinkage of the primary lesion and a reduction of lymph nodes. He was judged as clinical PR by RECIST, and a radical resection was considered possible. Laparotomy revealed neither ascites nor peritoneal dissemination, and he underwent total gastrectomy, splenectomy and D2+para-aortic lymph node dissection with curative intent. The histological diagnosis revealed complete disappearance of cancer cells in the primary lesion of the stomach and lymph nodes, confirming a pathological complete response. The patient has been alive for six months without recurrence.
|
Authors | Noriko Oshima, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masanori Tokunaga, Norihiko Sugisawa, Yusuke Taki, Yoko Motegi, Narikazu Boku, Keiko Sasaki, Masanori Terashima |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 37
Issue 4
Pg. 697-701
(Apr 2010)
ISSN: 0385-0684 [Print] Japan |
PMID | 20414029
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Drug Combinations
- S 1 (combination)
- Tegafur
- Oxonic Acid
- Cisplatin
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Cisplatin
(administration & dosage, therapeutic use)
- Drug Combinations
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Oxonic Acid
(administration & dosage, therapeutic use)
- Remission Induction
- Stomach Neoplasms
(diagnostic imaging, drug therapy, pathology, surgery)
- Tegafur
(administration & dosage, therapeutic use)
- Tomography, X-Ray Computed
|